Patents by Inventor Kanako Masuda

Kanako Masuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicines and medicinal kits
    Patent number: 7816399
    Abstract: It is intended to provide medicines having a higher ocular tension-lowering effect on ocular hypertension and glaucoma. Because of showing an excellent effect of lowering ocular tension, medicines comprising a combination of a prostaglandin compound with an NO-donating compound are useful in treating ocular hypertension and glaucoma.
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: October 19, 2010
    Assignees: Teika Pharmaceutical Co., Ltd., Kowa Company Ltd.
    Inventors: Masahiro Orihashi, Junpei Koike, Kanako Masuda
  • Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
    Patent number: 6825036
    Abstract: A novel MDCK-derived cell line (B-702) is provided that can be grown in the absence of fetal calf serum and in suspension culture for allowing a tank culture on the production scale and needs no carrier in suspension culture, as well as a process for producing virus for vaccine by using said cell line in a low-cost, highly safe and stable manner.
    Type: Grant
    Filed: September 3, 2002
    Date of Patent: November 30, 2004
    Assignee: Juridical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Keiichi Makizumi, Kanako Masuda, Yoichiro Kino, Sachio Tokiyoshi
  • Medicines and medicinal kits
    Publication number: 20040171681
    Abstract: It is intended to provide medicines having a higher ocular tension-lowering effect on ocular hypertension and glaucoma. Because of showing an excellent effect of lowering ocular tension, medicines comprising a combination of a prostaglandin compound with an NO-donating compound are useful in treating ocular hypertension and glaucoma.
    Type: Application
    Filed: October 20, 2003
    Publication date: September 2, 2004
    Inventors: Masahiro Orihashi, Junpei Koike, Kanako Masuda
  • Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
    Publication number: 20030044962
    Abstract: A novel MDCK-derived cell line (B-702) is provided that can be grown in the absence of fetal calf serum and in suspension culture for allowing a tank culture on the production scale and needs no carrier in suspension culture, as well as a process for producing virus for vaccine by using said cell line in a low-cost, highly safe and stable manner.
    Type: Application
    Filed: September 3, 2002
    Publication date: March 6, 2003
    Inventors: Keiichi Makizumi, Kanako Masuda, Yoichiro Kino, Sachio Tokiyoshi